Taken together our observations reveal a critical role for Lyn in promoting Claudin-2 expression in breast cancer cells, highlighting the potential of this specific SFK family member as an important therapeutic target in the management of liver metastasis. The gene discussed is CLDN2; the disease is breast carcinoma.